Skip to main content
Noah Hahn, MD, Oncology, Baltimore, MD, Sibley Memorial Hospital

NoahMHahnMD

Oncology • Baltimore, MD

Genitourinary Oncology, Hematologic Oncology

Professor of Oncology and Urology, Bladder Cancer Program Director at Johns Hopkins University School of Medicine, Deputy Director of the Johns Hopkins Greenberg Bladder Cancer Institute

Join to view full profile

Dr. Hahn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hahn's full profile

Already have an account?

  • Office

    Bunting-Blaustein Cancer Research Building 1, Room 1M51
    1650 Orleans Street
    Baltimore, MD 21287
    Phone+1 443-287-2886
    Fax+1 410-367-2667
  • Is this information wrong?

Summary

  • I am a professor of oncology and urology at the Johns Hopkins University School of Medicine. I serve as the director of the medical oncology bladder cancer program and the deputy director of the Johns Hopkins Greenberg Bladder Cancer Institute. Throughout my career, I have led numerous bladder cancer novel therapeutic clinical trials and translational investigations. I maintain an active clinical practice and see patients with urothelial cancers of all locations and stages including non-muscle invasive bladder cancer. My clinical and translational research interests focus on improving outcomes for patients with urothelial cancers through: 1) The development of novel epigenetic, targeted, and immunomodulatory approaches to treat and prevent urothelial cancer; 2) The credentialing of the naturally-occurring, immunocompetent canine-human tumor model as a relevant comparative oncology model optimal for the pre-clinical study of candidate human urothelial cancer biomarkers and therapeutics; and 3) The identification and validation of predictive biomarkers relevant to urothelial cancers. In addition to my efforts at Johns Hopkins, I also serve as the bladder cancer chairman of the Eastern Cooperative Oncology Group (ECOG), am the immediate past co-chair of the Hoosier Cancer Research Network genitourinary oncology clinical trials working group, participate on the NCI Bladder Cancer Task Force, and serve on the scientific advisory board of the Bladder Cancer Advocacy Network.

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2001 - 2003
  • Emory University School of Medicine
    Emory University School of MedicineInternship, Transitional Year, 2000 - 2001
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 2000

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2014 - 2024
  • DC State Medical License
    DC State Medical License 2018 - 2024
  • IN State Medical License
    IN State Medical License 2003 - 2015
  • NC State Medical License
    NC State Medical License 2001 - 2003

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Johns Hopkins Research Focused on Early Stage Bladder Cancer Wins $3.2 Million Federal Grant
    Johns Hopkins Research Focused on Early Stage Bladder Cancer Wins $3.2 Million Federal GrantJuly 1st, 2019
  • Does Immuno-Oncology Therapy Have a Larger Role in the Urology Clinic?
    Does Immuno-Oncology Therapy Have a Larger Role in the Urology Clinic?June 21st, 2019
  • Consultations and Infusion 55
    Consultations and Infusion 55December 13th, 2018

Professional Memberships

Hospital Affiliations

External Links

Dr. Noah Hahn, Dr. Noah Hahn, MD, Dr. N Hahn, Dr. Noah M Hahn